Tesamorelin 10mg
Tesamorelin research material is supplied in a 3 mL cartridge containing 10 mg Tesamorelin reconstituted in 3 mL bacteriostatic water. The cartridge is designed for use with the supplied reusable research pen in controlled scientific, analytical, and laboratory research environments.
Tesamorelin 10 mg Disposable Research Pen — Research Use Only
Tesamorelin is a synthetic peptide supplied exclusively as a laboratory research material for scientific, analytical, and documentation purposes. This product is intended solely for use in controlled research environments and is presented in a neutral catalog format designed to support procurement, inventory management, traceability, and laboratory workflows.
This product is supplied in a disposable research pen format containing 10 mg Tesamorelin reconstituted in 3 mL bacteriostatic water.
The purpose of this listing is to describe Tesamorelin strictly as a research compound. No therapeutic, physiological, nutritional, cosmetic, performance-related, or medical claims are stated or implied. All information provided is intended for catalog identification and laboratory reference purposes only.
Tesamorelin 10 mg — Specifications
Tesamorelin is supplied in a pre-prepared disposable research pen format for controlled laboratory research applications.
- Product: Tesamorelin
- Material: Synthetic peptide research material
- Quantity: 10 mg
- Format: Disposable Research Pen
- Solution Volume: 3 mL
- Preparation: 10 mg Tesamorelin reconstituted in 3 mL bacteriostatic water
- Packaging: Disposable research pen system
- Intended Use: Laboratory research and analytical applications only
Package Contents
- 1 × Disposable Research Pen
- Contains 10 mg Tesamorelin reconstituted in 3 mL bacteriostatic water
Research Grade Tesamorelin
The designation Research Grade indicates that this material is supplied exclusively for scientific research, analytical procedures, laboratory documentation, method development, and controlled testing environments.
The terminology used throughout this page follows a compliance-focused catalog structure intended to clearly identify the product as laboratory research material.
This listing intentionally avoids dosage instructions, administration guidance, outcome-based language, performance claims, or recommendations for personal use.
The product is not intended for human, veterinary, cosmetic, pharmaceutical, therapeutic, diagnostic, or nutritional applications.
Laboratory Context
Within scientific environments, Tesamorelin research material may be referenced in laboratory workflows that prioritize analytical consistency, documentation accuracy, and controlled experimental procedures.
Typical laboratory activities may include:
- Peptide identity verification
- Analytical comparison studies
- Method development and validation
- Stability assessments
- Reference material evaluation
- Research material inventory management
- Synthetic peptide library evaluation
- Documentation and traceability procedures
These examples describe general laboratory activities only and do not imply biological effects, efficacy, therapeutic benefits, or intended clinical applications.
Disposable Research Pen Format
The disposable research pen provides a self-contained format for controlled laboratory workflows requiring consistent handling and dispensing of research material.
The pen is supplied as a single disposable research system and is not described or marketed for human or veterinary administration.
EU Stock & Logistics
Where identified as EU Stock, inventory is maintained within the European Union to support predictable shipping and simplified logistics for European research customers.
Consistent packaging and tracked delivery can support laboratory receiving, inventory registration, procurement, and documentation workflows.
Handling & Storage
Tesamorelin research material should be stored and handled according to applicable product documentation, institutional laboratory protocols, and internal SOPs.
Handling, storage, and disposal should be performed by appropriately trained personnel in accordance with applicable laboratory procedures and relevant regulations.
Related Research Products
- CJC-1295 No DAC
- Ipamorelin
- CJC-1295 No DAC + Ipamorelin
- Bacteriostatic Water 10 mL
Research Use Only
FOR RESEARCH USE ONLY (RUO)
NOT FOR HUMAN OR VETERINARY USE
NOT FOR HUMAN OR ANIMAL CONSUMPTION
NOT FOR HUMAN OR VETERINARY INJECTION OR ADMINISTRATION
NOT FOR THERAPEUTIC OR DIAGNOSTIC USE
NOT FOR CLINICAL, COSMETIC OR NUTRITIONAL USE
Tesamorelin 10 mg Disposable Research Pen is supplied exclusively as laboratory research material and should be handled only by appropriately trained personnel within suitable research environments.
FAQ
Q: What does Research Grade mean?
A: Research Grade indicates that the product is supplied exclusively for laboratory research and scientific reference purposes.
Q: What does the disposable research pen contain?
A: It contains 10 mg Tesamorelin reconstituted in 3 mL bacteriostatic water.
Q: What is the solution volume?
A: The disposable research pen contains 3 mL of prepared research material.
Q: Is the pen reusable?
A: No. This product is supplied as a disposable research pen.
Q: Is this product intended for human use?
A: No. It is supplied strictly for laboratory research and is not intended for human or veterinary consumption, injection, or administration.
Q: What is the purpose of the disposable pen format?
A: The format provides a self-contained dispensing platform for appropriate controlled laboratory workflows. research personnel.
Every lot is tested by an independent laboratory before release. No certificate has been published for the lot currently shipping.
No purity figure is claimed for this lot until the laboratory returns. Once it does, the certificate is published in the COA library against its lot number.
Reference material only. Any listing here exists so researchers can locate primary literature; its presence is not a claim of any effect, and HPL makes no representation as to outcomes.
- Published in final edited form as: AIDS. 2021 Jul 15;35(9):1395–1402. doi: 10.1097/QAD.0000000000002897Open →
